Pricing Log in Create free account

BioVie Inc. (BIVI) vs Palatin Technologies, Inc. (PTN)

BioVie Inc. and Palatin Technologies, Inc. are both Biotechnology companies. BioVie Inc. and Palatin Technologies, Inc. are of similar size ($10.3M and $10.2M). BioVie Inc. has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 12.2×. BioVie Inc. has the higher net margin (0.00% vs −63.5%) and the lower return on invested capital (−1,095.0% vs 0.00%). Across the 13 metrics below, BioVie Inc. leads on 7 and Palatin Technologies, Inc. on 6.

Valuation

Metric BIVI PTN Biotechnology median
P/E n/m 12.21 10.26
P/S n/m 1.23 9.18
P/B 0.85 2.43 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 0.67 8.98
Earnings yield (260.33%) 8.19% (34.89%)
Free cash flow yield (216.99%) (83.75%) (24.52%)

Profitability

Metric BIVI PTN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (65.74%) 0.00%
Net margin 0.00% (63.54%) 0.00%
Free cash flow margin 0.00% (103.07%) 0.00%
Return on equity (151.06%) (877.60%) (50.12%)
Return on assets (123.51%) (142.11%) (45.60%)
Return on invested capital (1,095.01%) 0.00% 0.00%

Growth

Metric BIVI PTN Biotechnology median
Revenue growth (TTM) — 110.89% 6.26%
EPS growth (last fiscal year) 74.83% 90.80% 29.88%
Revenue growth, 5-year CAGR — 156.83% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIVI PTN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.59 4.61 4.89
Net debt to EBITDA 0.40 0.87 1.01

Dividend

Metric BIVI PTN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BIVI PTN Biotechnology median
Market cap 10.32m 10.17m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack